Related Experiment Video
Updated: May 17, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Mechanistic insights into Circ-MBOAT2-mediated regulation of TLK1 through miR-664b-3p in non-small cell lung cancer
DanTing Zhao1, Cong Wang1, GuangCheng Zhang1
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Shandong First Medical University, No. 366 Taishan Street, Taishan District, Tai'an City, Shandong Province, 271000, China.
Background:
Emerging evidence highlights the critical involvement of dysregulated circular RNAs (circRNAs) in non-small cell lung cancer (NSCLC) pathogenesis. Nevertheless, the precise functional role and mechanistic contributions of circ-MBOAT2 in NSCLC remain poorly characterized. The purpose of this study was to investigate the pathogenesis of NSCLC based on circ-MBOAT2.
Methods:
Our investigation focused on the interplay among circ-MBOAT2, miR-664b-3p, and Tousled-like kinase 1 (TLK1) mRNA in NSCLC tissues, along with their association with the clinical and pathological characteristics of NSCLC patients. Sequences or plasmids were transfected into A549 cells. Gene expressions were identified using RT-qPCR and Western blot analysis. NSCLC cells' cancerous characteristics were identified using CCK-8, EdU, AnnexinV-PI double staining, and Transwell, while their in vivo growth was assessed through a xenografted tumor assay. To monitor alterations in the CD8+ T cell ratio and inflammatory factors in PBMCs, co-cultures were created with both normal human PBMCs and A549 cells. Evaluations using bioinformatics software, dual luciferase reporter tests, and RIP assays were performed to verify the connection between circ-MBOAT2 and miR-664b-3p, as well as the interaction between miR-664b-3p and TLK1.
Results:
Circ-MBOAT2 expression was up-regulated in NSCLC, and reducing circ-MBOAT2 hampered NSCLC cell proliferation, EMT, immune escape, and tumor growth in vivo. There was a negative correlation between miR-664b-3p expression and circ-MBOAT2, and miR-664b-3p could compete with circ-MBOAT2 for binding. miR-664b-3p downregulation impaired the anti-tumor effect of circ-MBOAT2 reduction on NSCLC cells. TLK1 expression was elevated in NSCLC specimens compared to adjacent normal tissues (p < 0.001), negatively correlated with miR-664b-3p (r=-0.351, p < 0.001), and positively correlated with circ-MBOAT2 (r = 0.341, p < 0.001). In vitro functional experiments showed that silencing TLK1 restrained NSCLC cell proliferation, EMT, and immune escape, whlie TLK1 overexpression rescued the inhibitory effects of miR-664b-3p on NSCLC cell malignant behaviors.
Conclusion:
Circ-MBOAT2 promotes NSCLC cell proliferation, EMT and immune escape by competitively binding to miR-664b-3p to promote TLK1 expression.
Insights
Circular RNA MBOAT2 (circ-MBOAT2) promotes non-small cell lung cancer (NSCLC) progression by interacting with miR-664b-3p to increase TLK1 expression. Reducing circ-MBOAT2 inhibits NSCLC cell growth and immune escape.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly implicated in non-small cell lung cancer (NSCLC) pathogenesis.
- The specific role of circ-MBOAT2 in NSCLC remains largely unknown.
- Understanding circRNA mechanisms is crucial for developing novel NSCLC therapies.
Purpose of the Study:
- To elucidate the pathogenic role of circ-MBOAT2 in NSCLC.
- To investigate the molecular interactions involving circ-MBOAT2, miR-664b-3p, and TLK1 in NSCLC.
- To assess the therapeutic potential of targeting the circ-MBOAT2 pathway.
Main Methods:
- Analysis of circ-MBOAT2, miR-664b-3p, and TLK1 expression in NSCLC tissues.
- In vitro studies using NSCLC cell lines (A549) involving gene transfection and functional assays (CCK-8, EdU, AnnexinV-PI, Transwell).
- In vivo xenograft tumor assays and co-culture experiments with peripheral blood mononuclear cells (PBMCs) to assess immune modulation.
Main Results:
- Circ-MBOAT2 was upregulated in NSCLC and its reduction inhibited proliferation, epithelial-mesenchymal transition (EMT), immune escape, and tumor growth.
- A negative correlation was observed between circ-MBOAT2 and miR-664b-3p, with miR-664b-3p competing for binding.
- TLK1 was upregulated, negatively correlated with miR-664b-3p, and positively correlated with circ-MBOAT2; TLK1 silencing suppressed NSCLC progression.
Conclusions:
- Circ-MBOAT2 promotes NSCLC progression by sponging miR-664b-3p, leading to increased TLK1 expression.
- This circRNA-miRNA-mRNA axis drives NSCLC cell proliferation, EMT, and immune evasion.
- Targeting circ-MBOAT2 or the downstream pathway may offer a therapeutic strategy for NSCLC.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation

